Xermelo

Active substance

Telotristat etiprate

Holder

Ipsen

Status

Closed

Indication

Treatment of carcinoid syndrome diarrhea in combination with somatstatin analogue (SSA) therapy in adults inadequately controlled by SSA therapy.

Public documents

Approbation

Information for the patient

Informed consent

Last update

05/11/2018

Last updated on 23/04/2024